199 related articles for article (PubMed ID: 1388135)
1. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
Katira A; Kamal M; Gordon J
Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
Gordon J; Katira A; Strain AJ; Gillis S
Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
[TBL] [Abstract][Full Text] [Related]
4. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
Prinz JC; Baur X; Mazur G; Rieber EP
Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
[TBL] [Abstract][Full Text] [Related]
6. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
Zhang K; Clark EA; Saxon A
J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
[TBL] [Abstract][Full Text] [Related]
7. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
9. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes.
Dugas B; Renauld JC; Pène J; Bonnefoy JY; Peti-Frère C; Braquet P; Bousquet J; Van Snick J; Mencia-Huerta JM
Eur J Immunol; 1993 Jul; 23(7):1687-92. PubMed ID: 7686859
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes.
Wu CY; Sarfati M; Heusser C; Fournier S; Rubio-Trujillo M; Peleman R; Delespesse G
J Clin Invest; 1991 Mar; 87(3):870-7. PubMed ID: 1825666
[TBL] [Abstract][Full Text] [Related]
13. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
Delespesse G; Sarfati M; Peleman R
J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
16. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
Kawabe T; Maekawa N; Maeda Y; Hosoda M; Yodoi J
J Immunol; 1991 Jul; 147(2):548-53. PubMed ID: 1830067
[TBL] [Abstract][Full Text] [Related]
17. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
Berg DJ; Lynch RG
J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
[TBL] [Abstract][Full Text] [Related]
18. Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitro.
Maliszewski CR; Sato TA; Vanden Bos T; Beckmann MP; Grabstein KH
Eur J Immunol; 1990 Aug; 20(8):1735-40. PubMed ID: 2145164
[TBL] [Abstract][Full Text] [Related]
19. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo.
Hjulström S; Landin A; Jansson L; Holmdahl R; Heyman B
Eur J Immunol; 1995 May; 25(5):1469-72. PubMed ID: 7774652
[TBL] [Abstract][Full Text] [Related]
20. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
Flores-Romo L; Johnson GD; Ghaderi AA; Stanworth DR; Veronesi A; Gordon J
Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
